Table of Contents
<< Previous Issue | Dec 2021 (Vol: 2021, Issue: 12) | Next Issue >> |
- Section: Licensing
-
Astellas Partners with Dyno Therapeutics for Gene Therapy Technology
-
AstraZeneca Pays US$200 M Upfront for Ionis’ Rare Disease Drug
- Section: Mergers & Acquisitions
-
Vifor Enters Two Multimillion-Dollar Deals to Expand Nephrology Portfolio
-
Pfizer Acquires Immuno-Inflammatory Company Arena for US$6.7 B
-
CSL Hands Over US$11.7 B to Acquire Vifor Pharma